Open main menu
ICRPaedia β

Pages with the most revisions

Showing below up to 250 results in range #1 to #250.

View (previous 250 | next 250) (20 | 50 | 100 | 250 | 500)

  1. ICRP Glossary‏‎ (267 revisions)
  2. Application of ionising radiation in healthcare‏‎ (98 revisions)
  3. Information for healthcare providers‏‎ (80 revisions)
  4. Information for patients, family members, carers and the public‏‎ (62 revisions)
  5. System Of Radiation Protection Overview‏‎ (43 revisions)
  6. Guide to Radiological Protection in Healthcare‏‎ (43 revisions)
  7. General Information on Radon‏‎ (31 revisions)
  8. Main Page‏‎ (29 revisions)
  9. Information for patients, family members, carers and the public (old)‏‎ (24 revisions)
  10. Application of ionising radiation in healthcare (old)‏‎ (24 revisions)
  11. Information for healthcare providers (old)‏‎ (24 revisions)
  12. Effective dose‏‎ (23 revisions)
  13. Radon For Governments and Employers‏‎ (23 revisions)
  14. Radon For Homeowners and Residents‏‎ (22 revisions)
  15. The System of Radiological Protection‏‎ (21 revisions)
  16. Guide to Radon‏‎ (19 revisions)
  17. Tissue weighting factor‏‎ (17 revisions)
  18. List of ICRP Publications on Radiological Protection in Healthcare‏‎ (16 revisions)
  19. System of radiation protection module 2‏‎ (14 revisions)
  20. ICRP publications‏‎ (14 revisions)
  21. Quotes from Publications on the System of Radiological Protection‏‎ (13 revisions)
  22. Equivalent dose‏‎ (11 revisions)
  23. Absorbed, Equivalent, and Effective Dose‏‎ (10 revisions)
  24. Fundamental Principles of Radiological Protection‏‎ (9 revisions)
  25. Absorbed dose‏‎ (9 revisions)
  26. Objectives of Radiological Protection‏‎ (9 revisions)
  27. Air-kerma rate constant‏‎ (9 revisions)
  28. Organ/tissue absorbed dose‏‎ (8 revisions)
  29. Effects of Exposure‏‎ (8 revisions)
  30. Prudence‏‎ (8 revisions)
  31. Beneficence‏‎ (8 revisions)
  32. Collective effective dose‏‎ (7 revisions)
  33. Alimentary tract‏‎ (6 revisions)
  34. ICRPædia Guides‏‎ (6 revisions)
  35. Justice‏‎ (6 revisions)
  36. Accelerated fractionation‏‎ (6 revisions)
  37. Linear energy transfer‏‎ (6 revisions)
  38. Exposure Categories and Situations‏‎ (6 revisions)
  39. Investigation level‏‎ (6 revisions)
  40. Principle of optimisation‏‎ (5 revisions)
  41. ICRPædia Guide to the System of Radiological Protection‏‎ (5 revisions)
  42. Absorbed fraction‏‎ (5 revisions)
  43. Justification‏‎ (5 revisions)
  44. Kerma‏‎ (5 revisions)
  45. Protection quantities‏‎ (5 revisions)
  46. Types of materials‏‎ (5 revisions)
  47. Radiation weighting factor‏‎ (5 revisions)
  48. Air-kerma, entrance surface‏‎ (5 revisions)
  49. Sources of Radiation Exposure‏‎ (5 revisions)
  50. Dose coefficient‏‎ (5 revisions)
  51. Quality factor‏‎ (5 revisions)
  52. High linear energy transfer radiation‏‎ (4 revisions)
  53. S coefficient (radiation weighted)‏‎ (4 revisions)
  54. Non-maleficence‏‎ (4 revisions)
  55. Bioassay‏‎ (4 revisions)
  56. Calculating Radon Doses‏‎ (4 revisions)
  57. Computed tomography dose index‏‎ (4 revisions)
  58. Direct bioassay‏‎ (4 revisions - redirect page)
  59. Alpha decay‏‎ (4 revisions)
  60. Mass median diameter‏‎ (4 revisions)
  61. Math‏‎ (4 revisions)
  62. Effective charge number‏‎ (4 revisions)
  63. Programmed cell death‏‎ (4 revisions)
  64. Averted dose‏‎ (4 revisions)
  65. Effective half-life‏‎ (4 revisions)
  66. Reference Animal and Plant‏‎ (4 revisions)
  67. Kp index‏‎ (4 revisions)
  68. Protective action‏‎ (4 revisions)
  69. Forbiddenness‏‎ (4 revisions)
  70. Aerodynamic diameter‏‎ (4 revisions)
  71. ICRP‏‎ (4 revisions)
  72. Source-related assessment‏‎ (4 revisions)
  73. Reference bioassay function‏‎ (4 revisions)
  74. Risk‏‎ (4 revisions)
  75. Senescence‏‎ (4 revisions)
  76. Diagnostic reference level‏‎ (4 revisions)
  77. Air-kerma, product‏‎ (4 revisions)
  78. Fractionation sensitivity‏‎ (4 revisions)
  79. Optimisation‏‎ (4 revisions)
  80. Air kerma at the patient entrance reference point‏‎ (4 revisions)
  81. Sievert‏‎ (4 revisions)
  82. Absolute risk‏‎ (3 revisions)
  83. Auger transition‏‎ (3 revisions)
  84. Bystander effect‏‎ (3 revisions)
  85. Iso-effect plots‏‎ (3 revisions)
  86. Lifetime risk estimates‏‎ (3 revisions)
  87. Virtue ethics‏‎ (3 revisions)
  88. Emergency procedures‏‎ (3 revisions)
  89. Activity median thermodynamic diameter‏‎ (3 revisions)
  90. Isomers‏‎ (3 revisions)
  91. Complex tissues‏‎ (3 revisions)
  92. Derived air concentration‏‎ (3 revisions)
  93. Voxel phantom‏‎ (3 revisions)
  94. Dignity‏‎ (3 revisions)
  95. Employer‏‎ (3 revisions)
  96. Radiological Protection in Healthcare‏‎ (3 revisions - redirect page)
  97. Growth fraction‏‎ (3 revisions)
  98. Organ dose equivalent‏‎ (3 revisions)
  99. Extrathoracic airways‏‎ (3 revisions)
  100. Galactic cosmic radiation‏‎ (3 revisions)
  101. Growth hormone (somatotropin)‏‎ (3 revisions)
  102. ICRP Publication 103‏‎ (3 revisions)
  103. Excretion rate (instantaneous)‏‎ (3 revisions)
  104. Fairness‏‎ (3 revisions)
  105. Absorption‏‎ (3 revisions)
  106. Recovery‏‎ (3 revisions)
  107. Gamma ray‏‎ (3 revisions)
  108. Spread-out Bragg peak‏‎ (3 revisions)
  109. DNA damage signalling‏‎ (3 revisions)
  110. Field-size effect (Volume effect)‏‎ (3 revisions)
  111. Gastrointestinal syndrome‏‎ (3 revisions)
  112. Biomedical research volunteer‏‎ (3 revisions)
  113. Cardiomyopathy‏‎ (3 revisions)
  114. Wisdom‏‎ (3 revisions)
  115. Dose equivalent‏‎ (3 revisions)
  116. Flexible tissues‏‎ (3 revisions)
  117. Guide to the System of Radiological Protection‏‎ (3 revisions)
  118. Autonomy‏‎ (3 revisions)
  119. Target region‏‎ (3 revisions)
  120. Dose limit‏‎ (3 revisions)
  121. Fluence‏‎ (3 revisions)
  122. Constancy test‏‎ (3 revisions)
  123. Dose‏‎ (3 revisions)
  124. Dose limits‏‎ (3 revisions)
  125. Fluoroscopically guided interventions‏‎ (3 revisions)
  126. Annual dose‏‎ (3 revisions)
  127. DS02‏‎ (3 revisions)
  128. Potential exposure‏‎ (3 revisions)
  129. Accountability‏‎ (3 revisions)
  130. Half-life, physical‏‎ (3 revisions)
  131. Rigidity threshold‏‎ (3 revisions)
  132. Cell death‏‎ (3 revisions)
  133. Low Earth orbit‏‎ (3 revisions)
  134. Contamination‏‎ (3 revisions)
  135. X ray‏‎ (3 revisions)
  136. Dose of record (E)‏‎ (3 revisions)
  137. Exponential survival curve‏‎ (3 revisions)
  138. Annual limit on intake‏‎ (3 revisions)
  139. Unsealed source‏‎ (3 revisions)
  140. Xerostomia‏‎ (3 revisions)
  141. Graded approach‏‎ (3 revisions)
  142. Interphase death‏‎ (3 revisions)
  143. Test‏‎ (3 revisions)
  144. Dose per content function‏‎ (3 revisions)
  145. Public exposure‏‎ (3 revisions)
  146. Equity‏‎ (3 revisions)
  147. Fractionation‏‎ (3 revisions)
  148. Uptake‏‎ (3 revisions)
  149. Active (red) bone marrow‏‎ (3 revisions)
  150. Granulocyte-macrophage colony-stimulating factor‏‎ (3 revisions)
  151. Utilitarian ethics‏‎ (3 revisions)
  152. Operational quantity‏‎ (3 revisions)
  153. Granulocyte colony-stimulating factor‏‎ (3 revisions)
  154. Coster-Kronig transition‏‎ (3 revisions)
  155. Value judgement‏‎ (3 revisions)
  156. Gray‏‎ (3 revisions)
  157. Valvular heart disease‏‎ (3 revisions)
  158. Personal dose equivalent‏‎ (3 revisions)
  159. Principle of justification‏‎ (3 revisions)
  160. Emergency preparedness‏‎ (3 revisions)
  161. Radiofrequency ablation‏‎ (3 revisions)
  162. Representative organism (non-human biota)‏‎ (2 revisions)
  163. ICRPædia Guide to the Basics of Ionising Radiation‏‎ (2 revisions)
  164. Beta-minus decay‏‎ (2 revisions)
  165. Clearance level‏‎ (2 revisions)
  166. Threshold dose for tissue reactions‏‎ (2 revisions)
  167. Magnetosphere‏‎ (2 revisions)
  168. Dose constraint‏‎ (2 revisions)
  169. Early normal tissue responses‏‎ (2 revisions)
  170. Radiographer‏‎ (2 revisions)
  171. Exposure situation‏‎ (2 revisions)
  172. Growth factor‏‎ (2 revisions)
  173. Alimentary tract transfer factor‏‎ (2 revisions)
  174. Representative person‏‎ (2 revisions)
  175. Safety‏‎ (2 revisions)
  176. Beta-plus decay‏‎ (2 revisions)
  177. Calculating Doses from Intakes of Radionuclides‏‎ (2 revisions)
  178. Specific effective energy‏‎ (2 revisions)
  179. Limitation of dose‏‎ (2 revisions)
  180. Cumulative dose‏‎ (2 revisions)
  181. Transmission detection system‏‎ (2 revisions)
  182. Multistage tumorigenesis‏‎ (2 revisions)
  183. Non-sphericity parameter‏‎ (2 revisions)
  184. Dose conversion coefficient‏‎ (2 revisions)
  185. Pharynx‏‎ (2 revisions)
  186. Edema‏‎ (2 revisions)
  187. Excess relative risk‏‎ (2 revisions)
  188. Exposure to Radon at Home‏‎ (2 revisions)
  189. GATA binding protein 2‏‎ (2 revisions)
  190. Reproductive integrity‏‎ (2 revisions)
  191. Hormones‏‎ (2 revisions)
  192. Authorization‏‎ (2 revisions)
  193. Safety case‏‎ (2 revisions)
  194. Slow repair‏‎ (2 revisions)
  195. Isotropic geometry‏‎ (2 revisions)
  196. Clonogenic cells‏‎ (2 revisions)
  197. Lineal energy‏‎ (2 revisions)
  198. Thyroid blocking‏‎ (2 revisions)
  199. Curie‏‎ (2 revisions)
  200. Transparency‏‎ (2 revisions)
  201. Waste disposal‏‎ (2 revisions)
  202. Non-targeted effects‏‎ (2 revisions)
  203. Effect Dose 50‏‎ (2 revisions)
  204. Procedural values‏‎ (2 revisions)
  205. Endogeneous excretion‏‎ (2 revisions)
  206. Reasonableness‏‎ (2 revisions)
  207. Acute radiation syndrome‏‎ (2 revisions)
  208. Residual dose‏‎ (2 revisions)
  209. Hounsfield unit‏‎ (2 revisions)
  210. Authorized limit‏‎ (2 revisions)
  211. Safety culture‏‎ (2 revisions)
  212. Solar cosmic radiation‏‎ (2 revisions)
  213. Inhalability‏‎ (2 revisions)
  214. Cardiac arrhythmias‏‎ (2 revisions)
  215. Spontaneous fission‏‎ (2 revisions)
  216. Itinerant (radiation) worker‏‎ (2 revisions)
  217. Clonogenic survival‏‎ (2 revisions)
  218. Linear-non-threshold model‏‎ (2 revisions)
  219. Cytokines‏‎ (2 revisions)
  220. Trapped particles‏‎ (2 revisions)
  221. Orphan source‏‎ (2 revisions)
  222. Planned exposure situation‏‎ (2 revisions)
  223. Progenitor cell‏‎ (2 revisions)
  224. Radiation belt‏‎ (2 revisions - redirect page)
  225. Adaptive response‏‎ (2 revisions)
  226. Alveolar-interstitial region‏‎ (2 revisions)
  227. Respiratory protection‏‎ (2 revisions)
  228. Autoimmune disease‏‎ (2 revisions)
  229. Scintigraphy‏‎ (2 revisions)
  230. Solar cycle‏‎ (2 revisions)
  231. Inner bremsstrahlung‏‎ (2 revisions)
  232. ICRP Publication 118‏‎ (2 revisions)
  233. Cardiac valve diseases‏‎ (2 revisions)
  234. Systemic model‏‎ (2 revisions)
  235. Linear-quadratic dose response model‏‎ (2 revisions)
  236. Time factor‏‎ (2 revisions)
  237. Myocardial perfusion‏‎ (2 revisions)
  238. What is Radon?‏‎ (2 revisions)
  239. Disposal‏‎ (2 revisions)
  240. Dose criteria‏‎ (2 revisions)
  241. Platelet-derived growth factor‏‎ (2 revisions)
  242. Environmental exposure‏‎ (2 revisions)
  243. Radiation modifier‏‎ (2 revisions)
  244. Exempt waste‏‎ (2 revisions)
  245. Radiological protection principles‏‎ (2 revisions)
  246. Recovery (cellular or tissue)‏‎ (2 revisions)
  247. Retrievability‏‎ (2 revisions)
  248. Immune system‏‎ (2 revisions)
  249. Institutional control‏‎ (2 revisions)
  250. Stakeholder‏‎ (2 revisions)

View (previous 250 | next 250) (20 | 50 | 100 | 250 | 500)

Retrieved from "http://icrpaedia.org/Special:MostRevisions"